You searched for
Tag:
Corporate
LEED certification: Chiesi's commitment for the sustainability of its buildings
31/05/2023
A behavioral therapy app to close the access gap in COPD treatment
18/04/2023
World Health Day: our commitment to provide Health For All
07/04/2023
European Parliament vote on the revision of the EU’s legislative framework on F-gas: climate targets need innovative solutions
03/04/2023
In 2022 Chiesi Group has been confirmed as the 1st Italian pharmaceutical company for the number of patents filed
28/03/2023
What does it mean to be a B Corp? Chiesi's choice for a sustainable future
01/03/2023
Rare Disease Day
28/02/2023
Chiesi Group stands in solidarity with the people of #Turkiye and #Syria
09/02/2023
The Alphabet of Sustainability
01/02/2023
Energize Programme: a shared commitment to accelerate the adoption of renewable energy in the pharmaceutical sector
17/11/2022
“Vendor Day”: the role of Chiesi Group’s Value Chain in shaping the future
16/11/2022
Fostering innovation for rare diseases in Europe: Chiesi supports the RDR Challenges Call
27/10/2022
Giacomo Chiesi awarded by PharmaVoice100
09/09/2022
A new EU proposal to protect people and planet by reducing F-gases
01/08/2022
Chiesi Group joins Biden Administration pledge to decarbonize healthcare sector
06/07/2022